Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.00126
-0.00016 (-11.27%)
At close: Oct 16, 2026
Halberd Market Cap
Halberd has a market cap or net worth of $941.6 thousand as of October 16, 2026. It is the 49,158th most valuable company in the world and the 6,685th biggest in the United States. Its market cap has decreased by 44.53% in one year.
Market Cap
941.60K
Enterprise Value
n/a
Revenue
6.94K
Global Rank
Country Rank
#6,685 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 25, 2009, Halberd's market cap has decreased from 2.61M to 941.60K, a decrease of -63.87%. That is a compound annual growth rate of -5.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 941.60K | -11.25% |
| Dec 31, 2025 | 1.06M | -58.29% |
| Dec 31, 2024 | 2.54M | -11.40% |
| Dec 29, 2023 | 2.87M | -4.05% |
| Dec 30, 2022 | 2.99M | -62.35% |
| Dec 31, 2021 | 7.95M | -4.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NKGen Biotech | 1.44M |
| Avenue Therapeutics | 1.42M |
| Protagenic Therapeutics | 1.36M |
| inTerra Resources | 1.30M |
| AXIM Biotechnologies | 1.23M |
| Aditxt | 1.20M |
| Evofem Biosciences | 927.71K |
| Agentix | 801.34K |